It has been reported that liver transplantation (LT) recipients require less pain control postoperatively than patients undergoing other abdominal surgery [1] [2] [3] . This is important because inappropriate use of analgesic after LT may result in excessive sedation and delayed weaning from mechanical ventilation [4] . Although elevated endogenous opioids during end-stage liver disease was thought to be the cause of decreased analgesic requirement in LT recipients, the precise mechanism has not been clarified [5] . Recently, we performed living donor LT between monozygotic twins. Because pain thresholds might be similar in monozygotic twins due to their near complete genetic similarity, we could compare the analgesic requirements of the LT recipient with those of the donor with reduced influence of differences in innate pain thresholds.
Postoperative pain is severe immediately after surgery. The VAS score of the recipient in the present case was high on PODs 1 and 2, then gradually decreased (Fig. 1A) . Conversely the VAS score of the donor increased after POD 2 (Fig. 1B) .
This unusual pattern in the donor's VAS scores is probably due to the intrathecal morphine, the analgesic effects of which lasted until POD 2 [6] . Although the actual VAS AUC value was lower in the donor than in the recipient (Fig. 1C) , it is reasonable to assume that the VAS AUC value would have been larger in the donor than in the recipient were it not for the effects of intrathecal morphine [6] . The amounts of opioids administered during intraoperative and postoperative periods were converted to intravenous morphine equivalent doses (intravenous morphine:intrathecal morphine:pethi dine:fentanyl:hydromorphone = 1.00:0.10:10.00:0.01:0.15) ( Fig. 2) . Even if the non-opioid analgesic is excluded, the total amount of analgesic use was less in the recipient than in the donor.
We can suggest several reasons for the comparatively lower analgesic requirement in an LT recipient. One is that pharmacokinetic changes in patients with end-stage liver disease may affect the metabolism of drugs. Decreased hepatic blood flow, drug-metabolizing enzyme activity, and drug-bound plasma protein could be contributing factors [7, 8] . should be a primary aim [13] .
Although in the present case the LT recipient needed less analgesic than the donor after the surgery, there is one major limitation. It was not possible to accurately compare the VAS scores or total analgesic consumption of the two patients because of the different analgesic and pain control techniques used in each patient. However, the observations in the two patients are generally concordant with previous reports that LT recipients may tend to use less analgesic than LT donors during postoperative days.
In conclusion, in the present case involving an LT donor and an LT recipient who were almost genetically identical, the recipient required less analgesic than the donor for postoperative pain relief. Moreover, fine adjustment of the analgesic regimen is needed in both the LT recipient and the LT donor, based on the analgesic technique used.
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